A study to determine if three different doses of a new acne treatment are safe and better at
reducing facial acne than a treatment without active ingredient.
Phase:
Phase 2
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.